Fresenius threatened by class action lawsuit in U.S.

Frankfurt London.
Frankfurt. The world's largest dialysis company Fresenius Medical Care (FMC) threatened because of inadequate information on side effects of dialysis solutions, a class action in the United States. A group of patient advocates had filed an application process against the Company, the subsidiary of the Fresenius health care group said yesterday in Bad Homburg. Accordingly, pending in the U.S. product liability claims to be against the U.S. subsidiary of Fresenius Medical Care North America at the U.S. Department of Justice in Boston, Massachusetts, merged. These complaints relate to inadequate information about possible side effects on the labels of the two dialysis solutions NaturaLyte and GranuFlo.
FMC Chairman Ben Lipps assumes that these claims are unfounded. The company will however work with the U.S. Department of Justice.



Billion penalty for Swiss UBS?
London. The banking giant UBS may have to reach into his pocket depth for the Libor scandal. To settle the investigation by American and British authorities, the Swiss are more than a billion dollars to pay (€ 765 million), reported the financial news agency Bloomberg. The authorities and UBS did not want to comment.
The penalty could be announced as early as next week, it said in the circles. 'll Still struggled behind the scenes on the exact amount.
UBS is alleged that, together with other banks? including Barclays and the German bank? has manipulated the Libor, to gain such benefits. The Libor rate is the reference rate for many financial transactions.
UBS should actually shell out more than a billion dollars, it would be the highest ever penalty in terms of Libor